Month: November 2012

Android-based smartphones market share in Asia


Tonight I was wondering what was Android market share in Asia. It is 31% according to a recent study from Ericsson’s ConsumerLab group (reported by TechRepublic). Although dominant through most studied countries, Android is not dominant in Singapore (iOS has 46%), in Indonesia (RIM has 29%) nor in Vietnam (Symbian has 26%).

Last year ABI Research released a study where they showed that Android-based smartphones market share grew from 16% in 2010 to 52% in 2011 (but this included tablets and did not cover exactly the same countries as the Ericsson study). Voila πŸ™‚

Today is world diabetes day (Merck ends MK-0431E)

As WHO and other organisations are celebrating World Diabetes Day (WDD) it is always sad to read that a new potential drug is stopped.

This time Merck & co. stopped the clinical trial MK-0431E studying the co-administration of Sitagliptin and Atorvastatin in inadequately controlled Type 2 Diabetes Mellitus. Merck cites “business reasons” without further explanations.

SitagliptinΒ is sold under the trade name Januvia. It is an oral antihyperglycemic and one of the (if not the) best selling product of Merck with US$975 million revenue in the third quarter of 2012. On the other hand Atorvastatin is a statin lowering blood cholesterol. It was a blockbuster for Pfizer (sold under the trade name of Lipitor) until its patent expired.

Combining these two molecules made biological sense in order to reduce the number of medications that diabetic patients take. Of course combining two blockbusters (including one which patent expired) is a nice attempt to maintain drugs and positions on market.

Happy Halloween! (Pharma Q3 results and job losses so far)

Happy Halloween! It’s the season for Q3 reports a bit everywhere so also in Pharma: Abbott (↑), Elan (↑), Eli Lilly (↓), Bristol-Myers Squibb (↓), Sanofi (↓), Novartis (↓), Shire (↑), AstraZeneca (↓), Merck & Co (↑), Novo Nordisk (↑), GlaxoSmithKline (↓), …

At approximately the same time came a FirstWord List about the largest layoffs in Pharma so far (2012) … I just plotted the losses so far below. Spooky!

Layoffs in Pharma so far (2012)

I wish I were not that connected


We had a fixed phone line at home. We had a fixed phone line on our desk at the office. There was a letterbox in front of the house and a pigeon hole at some central location in the office.
And we were not reachable when sleeping, when in meeting, when commuting, …


We have a fixed phone line at home. We have a fixed phone line on our desk at the office. We have a mobile phone in our pocket or connected to the hands-free system in the car. The computers and tablet are running Skype or another communication software that shows every contact if we are “available”, “busy” or “not to be disturbed”. There are still letterboxes and pigeon holes but also e-mails, instant messaging, …
The fixed lines fall back on the mobile if there is no answer after 5 tones. We are reachable when sleeping, when in meeting, when commuting, … People call you when you don’t answer their e-mail after 5-10 minutes.

Next week:

I will be abroad, following some conference. What if I only carry a wifi-enabled music player running just Skype? I will be reachable between talks not during talks, at the conference center but not when commuting, at the hotel but not when reading or sleeping. Will it really make a difference? I wish I were not that connected.

P.S. of course this is a first world problem: